Rapid immunochromatographic strip test for the detection of albuminuria and brief literature review on albuminuria screening

European Journal of Medical Research

Volumn 11, Issue 1, 2006, Pages 3-6

  Pfab, T ^a   Franz, U ^a   Herfeld, F ^a   Lun, A ^a   Armbruster, F ^b   Hocher, Berthold ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Preventis   (Germany)

Author keywords

Albuminuria; Cardiovascular diseases; Dipstick test; Microalbuminuria; Predictive marker; Rapid test; Renal diseases; Sensitivity; Specificity; Validity

Indexed keywords

ALBUMIN; CREATININE;

ADOLESCENT; ADULT; AGED; ALBUMINURIA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; GERMANY; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; MALE; MICROALBUMINURIA; QUANTITATIVE ANALYSIS; REVIEW; ROC CURVE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TURBIDIMETRY; URINALYSIS; URINARY EXCRETION; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; HUMANS; IMMUNOLOGIC TESTS; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 32344448248     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Weir MR (2004) Microalbuminuria in type 2 diabetics: an important, overlooked cardiovascular risk factor. J Clin Hypertens (Greenwich) 6: 134-141
2. Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Okin PM, Omvik P, Oparil S, Wedel H, Snapinn SM, Aurup P (2003) Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 139: 901-906
3. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K (2000) Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 35: 898-903
4. Pontremoli R (1996) Microalbuminuria in essential hypertension--its relation to cardiovascular risk factors. Nephrol Dial Transplant 11: 2113-2115
5. Kannel WB, Stampfer MJ, Castelli WP, Vetter J (1984) The prognostic significance of proteinuria: the Framingham study. Am Heart J 108: 1347-1352
6. Romundstad S, Holmen J, Kvenild K, Hallan H, Ellekjaer H (2003) Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trondelag Health Study (HUNT), Norway. Am J Kidney Dis 42: 466-473
7. Murtaugh MA, Jacobs DR, Jr., Yu X, Gross MD, Steffes M (2003) Correlates of urinary albumin excretion in young adult blacks and whites: the Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol 158: 676-686
8. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE (2002) Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106: 1777-1782
9. Roest M, Banga JD, Janssen WM, Grobbee DE, Sixma JJ, de Jong PE, de Zeeuw D, Der Schouw YT (2001) Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women. Circulation 103: 3057-3061
10. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS (1999) Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 19: 1992-1997
11. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE (1990) Microalbuminuria as predictor of increased mortality in elderly people. BMJ 300: 297-300
12. Weir MR and Blantz RC (2005) The clinical utilization of albuminuria as a surrogate measure of cardiovascular disease burden and risk for events: are we there yet? Curr Opin Nephrol Hypertens 14: 39-41
13. Leoncini G, Sacchi G, Ravera M, Viazzi F, Ratto F, Vettoretti S, Parodi D, Bezante GP, Del Sette M, Deferrari G, Pontremoli R (2002) Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension. J Hum Hypertens 16: 399-404
14. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A (1989) Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32: 219-226
15. Atkins RC, Briganti EM, Lewis JB, Hunsicker LG, Braden G, Champion de Crespigny PJ, Deferrari G, Drury P, Locatelli F, Wiegmann TB, Lewis EJ (2005) Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. Am J Kidney Dis 45: 281-287
16. de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM (2004) Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 65: 2309-2320
17. Ibsen H, Wachtell K, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlof B, Devereux RB, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wan Y (2004) Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy. J Hypertens 22: 1805-1811
18. Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, Marcantoni C, de Jong PE, de Zeeuw D, Shahinfar S, Ruggenenti P, Remuzzi G, Levey AS (2001) Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int 60: 1131-1140
19. Bakris G (2004) Inclusion of albuminuria in hypertension and heart guidelines. Kidney Int Suppl S124-S125
20. de Jong PE and Brenner BM (2004) From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria. Kidney Int 66: 2109-2118
21. Mogensen CE, Chachati A, Christensen CK, Close CF, Deckert T, Hommel E, Kastrup J, Lefebvre P, Mathiesen ER, Feldt-Rasmussen B,. (1985) Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 9: 85-95
22. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H, Appleyard M, Jensen JS (2004) Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110: 32-35
23. Mainous AG, III and Gill JM (2001) The lack of screening for diabetic nephropathy: evidence from a privately insured population. Fam Med 33: 115-119
24. Kraft SK, Lazaridis EN, Qiu C, Clark CM, Jr., Marrero DG (1999) Screening and treatment of diabetic nephropathy by primary care physicians. J Gen Intern Med 14: 88-97
25. Boero R, Prodi E, Elia F, Porta L, Martelli S, Ferraro L, Quarello F (2003) How well are hypertension and albuminuria treated in type II diabetic patients? J Hum Hypertens 17: 413-418
26. Fernandez F, I, Paez Pinto JM, Hermosin BT, Vazquez GP, Ortiz Camunez MA, Tarilonte Delgado MA (1998) Rapid screening test evaluation for microalbuminuria in diabetes mellitus. Acta Diabetol 35: 199-202
27. Mogensen CE, Viberti GC, Peheim E, Kutter D, Hasslacher C, Hofmann W, Renner R, Bojestig M, Poulsen PL, Scott G, Thoma J, Kuefer J, Nilsson B, Gambke B, Mueller P, Steinbiss J, Willamowski KD (1997) Multicenter evaluation of the Micral-Test II test strip, an immunologic rapid test for the detection of microalbuminuria. Diabetes Care 20: 1642-1646
28. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139: 137-147
29. Gilbert RE, Akdeniz A, Jerums G (1997) Detection of microalbuminuria in diabetic patients by urinary dipstick. Diabetes Res Clin Pract 35: 57-60
30. Zheng YL, Liao J, Takeda Y, Io H, Kobata M, Kanamaru Y, Maeda A, Shou I, Igari J, Tomino Y (1999) Determination of sensitivity and specificity of the Micral-Test II strip for detection of microalbuminuria in diabetic and nondiabetic patients. Nephron 81: 455